| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |